An overview of the Short Term Scientific Mission undertaken by Assistant professor Emina Milosevic from the Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade. Emina was hosted by Professor Hildegard Greinix, Head of Division of Haematology, Medical University of Graz, LKH-Univ. Klinikum Graz.
I am Darija Bogdanić and currently, I am working as a transfusion medicine resident at the Clinical Department for Transfusion Medicine and Transplantation Biology of the University Hospital Centre Zagreb, Zagreb, Croatia; also I am a PhD student in Molecular Biosciences at the University of Osijek, Croatia.
I am Joanna Wielińska, a PhD student in Professor Katarzyna Bogunia-Kubik’s Laboratory of Clinical Immunogenetics and Pharmacogenetics at the Hirszfeld Institute of Immunology and Experimental Therapy in Wroclaw, Poland.
My name is Piotr Łacina and I am a PhD student supervised by Professor Katarzyna Bogunia-Kubik at Laboratory of Clinical Immunogenetics and Pharmacogenetics of the Hirszfeld Institute of Immunology and Experimental Therapy in Wroclaw, Poland.
How molecular biology and pharmacogenetics can help to understand the immune system’s behavior during the treatment of cGVHD with immunotherapy: the role of PD-L1, Torquetenovirus and of the assessment of tyrosine kinase inhibitors plasma levels.
I am Francesca Perutelli and I am a medical doctor at the Department of Haematology of the University of Pisa, Italy. In January went to Newcastle for a 2-month STSM for Working Group 2 on ‘Molecular and Cellular Biomarkers of Chronic Graft versus Host Disease (cGvHD)’.